WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock Ownership - Who owns Axsome Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Axsome Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nick PizzieChief Financial Officer2025-02-143,000$3.50
$10.50kBuy
Nick PizzieChief Financial Officer2025-02-143,000$131.07
$393.21kSell
Nick PizzieChief Financial Officer2025-02-1312,000$3.50
$42.00kBuy
Nick PizzieChief Financial Officer2025-02-1312,000$129.86
$1.56MSell
Mark ColemanDirector2025-01-039,127$9.00
$82.14kBuy
Mark ColemanDirector2024-11-1933,410$5.94
$198.46kBuy
Mark E. SaadDirector2024-09-1111,016$91.31
$1.01MSell
Mark E. SaadDirector2024-09-1111,016$3.67
$40.43kBuy
Mark L. JacobsonChief Operating Officer2024-08-0947,739$4.04
$192.87kBuy
Mark L. JacobsonChief Operating Officer2024-08-0947,739$84.26
$4.02MSell

1 of 2

AXSM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AXSM insiders and whales buy or sell their stock.

AXSM Shareholders

What type of owners hold Axsome Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Herriot Tabuteau15.08%7,351,729$757.23MInsider
Antecip Capital LLC15.06%7,344,500$756.48MInsider
Rtw Investments LP8.31%4,051,365$417.29MInstitution
Vanguard Group Inc8.00%3,902,479$401.96MInstitution
Blackrock Inc7.25%3,533,394$363.94MInstitution
Fairmount Funds Management LLC3.01%1,468,983$151.31MInstitution
Bvf Inc2.85%1,388,064$142.97MInstitution
Fmr LLC2.05%1,000,446$103.05MInstitution
Ra Capital Management LP2.05%1,000,000$103.00MInstitution
Macquarie Group Ltd1.98%964,047$99.30MInstitution

1 of 3

AXSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AXSM70.18%29.82%Net BuyingNet Buying
ADMA78.41%21.59%Net SellingNet Selling
NUVL74.75%25.25%Net SellingNet Selling
KRYS78.59%21.41%Net SellingNet Selling
VRNA10.10%52.80%Net SellingNet Buying
View Top Biotech Stocks

Axsome Therapeutics Stock Ownership FAQ

Who owns Axsome Therapeutics?

Axsome Therapeutics (NASDAQ: AXSM) is owned by 76.22% institutional shareholders, 32.39% Axsome Therapeutics insiders, and 0.00% retail investors. Herriot Tabuteau is the largest individual Axsome Therapeutics shareholder, owning 7.35M shares representing 15.08% of the company. Herriot Tabuteau's Axsome Therapeutics shares are currently valued at $763.26M.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.